InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,103.54
(
1.09%
)
US TECH 100
17,240.40
(
1.55%
)
Dow Jones
38,240.06
(
0.41%
)
Brent Oil
88.24
(
0.10%
)
Bitcoin
63,511.26
(
-1.51%
)
Post# of 251611
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: None

Thursday, 07/24/2014 7:34:24 AM

Thursday, July 24, 2014 7:34:24 AM

Post# of 251611
Damn! It is not easy being a SRPT investor!

http://www.sec.gov/Archives/edgar/data/873303/000119312514277845/d763233d8k.htm

On July 22, 2014, Arthur Krieg, M.D., Senior Vice President and Chief Scientific Officer of Sarepta Therapeutics, Inc. (the “Company”), was terminated from his position with the Company.



This can't be good news.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up